Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of a topical methyl 3,4,5-trihydroxybenzoate microemulsion ointment
RBR-249zxxhPhase 1Not yet recruiting
- Sponsor
- Universidade Federal do Amazonas
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cutaneous leishmaniasis (CL) (2 arms), sponsored by Universidade Federal do Amazonas. Planned start Mar 2023; status: not yet recruiting.
02
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on RBR-249zxxh.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-249zxxh.